oligo-lessions
Showing 1 - 25 of 125
Ovarian Cancer, Tumor, Ovarian, Ovarian Tumor Trial in Xi'an (chemo, targeted therapeutics, immunotherapy, IFRT, IMRT or SBRT)
Recruiting
- Ovarian Cancer
- +16 more
- chemotherapy, targeted therapeutics, immunotherapy
- IFRT, IMRT or SBRT
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi'an Jiao Tong University
Sep 25, 2021
Retrospective Cervical Cancer Oligo States Multicentre Outcomes
Not yet recruiting
- Cancer, Cervical
- +2 more
- Concurrent Chemoradiation, Systemic Chemotherapy other locally directed therapies (like surgery, ablation, etc.)
- (no location specified)
Nov 28, 2023
Colorectal Cancer, Liver Metastasis Colon Cancer Trial in Edmonton (stereotactic body radiation treatment (SBRT))
Not yet recruiting
- Colorectal Cancer
- Liver Metastasis Colon Cancer
- stereotactic body radiation treatment (SBRT)
-
Edmonton, Alberta, CanadaCross Cancer Institute
Mar 7, 2023
Metastatic Cancer Trial in Canada (Stereotactic Ablative Radiotherapy (SABR), Standard of Care Treatment)
Active, not recruiting
- Metastatic Cancer
- Stereotactic Ablative Radiotherapy (SABR)
- Standard of Care Treatment
-
Edmonton, Alberta, Canada
- +6 more
Aug 22, 2022
NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Esophageal Cancer
- +10 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)
Recruiting
- Brain Metastases
- Non-small Cell Lung Cancer
- EGFR-TK Inhibitor
- Stereotactic radiotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 27, 2023
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)
Recruiting
- Prostate Cancer
- +3 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Prediction of True Oligo-metastatic Disease.
Recruiting
- Oligometastatic Disease
- Genetic and immunologic assessments
-
Naples, ItalyAlessandro Ottaiano
Apr 7, 2023
HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)
Not yet recruiting
- HER2-positive Breast Cancer
- Trastuzumab deruxtecan
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Aug 7, 2023
NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)
Active, not recruiting
- Non-small Cell Lung Cancer
- +2 more
- Durvalumab
- +6 more
-
Milano, Italy
- +12 more
Dec 14, 2022
Irritable Bowel Syndrome, Obesity, Abdominal Obesity Trial (procedure, behavioral, other)
Not yet recruiting
- Irritable Bowel Syndrome
- +2 more
- focused ultrasound
- +2 more
- (no location specified)
May 30, 2023
Breast Cancer Trial in Shanghai
Not yet recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan university Shanghai Cancer Center
May 29, 2023
Radiation Toxicity Trial in Taipei (fucoidan)
Recruiting
- Radiation Toxicity
- fucoidan
-
Taipei, Please Select, TaiwanSzu-Yuan Wu
Nov 13, 2022
Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))
Active, not recruiting
- Oligoprogressive Renal Cell Carcinoma
- Stereotactic ablative body radiation (SABR)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 28, 2022
Oligometastatic Disease, NSCLC, Driver Mutation Trial in Mumbai (Local Consolidative Radiation Therapy, TKI)
Recruiting
- Oligometastatic Disease
- +2 more
- Local Consolidative Radiation Therapy
- TKI
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Mar 11, 2022
Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,
Recruiting
- Breast Cancer
- carboplatin, thiotepa, and cyclophosphamide
- chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
-
Amsterdam, NetherlandsNKI-AVL
Mar 21, 2022
Prostate Cancer Trial in Netherlands (Radiotherapy, Leuprorelin)
Recruiting
- Prostate Cancer
- Radiotherapy
- Leuprorelin
-
Leeuwarden, Friesland, Netherlands
- +12 more
Apr 5, 2022
ULTRASONOGRAPHIC EVALUATION OF OVARIAN STROMA IN PCOS WOMEN
Completed
- Ovarian Cysts
-
Usak, Turkeyİrem Şenyuva
Sep 18, 2022
Cachexia Trial in Taichung, Taipei (fucoidan)
Recruiting
- Cachexia
- fucoidan
-
Taichung, Please Select, Taiwan
- +1 more
Nov 13, 2022
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023
Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)
Recruiting
- Brain Metastases
- +2 more
- brain radiotherapy
- Almonertinib
-
Guangdong, Guangzhou, ChinaSun-Yat-Sen university
Mar 13, 2023
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
Recruiting
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Ferriman-Gallwey Score
-
Montreal, Quebec, CanadaClinique Ovo
Sep 22, 2022
Crohn Disease Trial (dietary pattern, EEN)
Not yet recruiting
- Crohn Disease
- dietary pattern
- EEN
- (no location specified)
Aug 14, 2022